✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals
Market Cap
₹24,755 Cr.
P/E
0.00

Key Ratios

Market cap
Market cap
24,755 Cr
PE
PE
-
Prom Holding
Prom Holding
49.09 %
ROE (%)
ROE (%)
-1.08
ROCE (%)
ROCE (%)
4.29
Div Yield (%)
Div Yield (%)
-
Sales
Sales
3,011 Cr
OPM (%)
OPM (%)
12.42 %
Debt to Equity
Debt to Equity
0.43
About
Wockhardt Limited is a global pharmaceutical and biotechnology organisation, providing afforda… Read more
Low
915
52W Range
High
1869
  • Wockhardt
  • Pfizer
  • Eris Lifesciences
  • TJI Pharma - Small Cap

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

8 Yes

Positive for this company

1 Neutral

Neutral for this company

8 No

Negative for this company

0 No Data

Insufficient data to analyse

Market Share
0.69 %
(as of Jul 22)
Anti - Diabetes - Market Share
0.05 %
(as of Jul 22)
Anti-Infectives - Market Share
0.01 %
(as of Aug 20)
Anti-Malarial - Market Share
0.05 %
(as of Nov 21)
Antineo Plastic - Market Share
4.31 %
(as of Nov 21)
Blood Related - Market Share
0 %
(as of Jul 22)
Cardiovascular - Market Share
Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Asset Break-Up

Operational Metrics

    Select a Metric
    • Domestic Sales Growth - YoY (%)
    • R&D as a % of Total Sales (%)
    Peer Comparison
    Brands
    Spasmo Proxyvon
    Corporate Actions
    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less
    Suppliers
    • Shaily Engineering Plastics Ltd.
    • Borosil Renewables Ltd.
    • Responsive Industries Ltd.
    • Hindusthan National Glass & Industries Ltd.
    • Vivimed Labs Ltd.
    FAQs on Wockhardt Ltd. Business

    Wockhardt Limited is a prominent Indian pharmaceutical and biotechnology company that prioritizes accessibility to high-quality medicines. They are active in Pharmaceuticals, Biotechnology, and Super Speciality Hospitals.

    Wockhardt major competitors are Pfizer, Eris Lifesciences, JB Chem & Pharma, Astrazeneca Pharma I, Alembic Pharma, Gland Pharma, Jubilant Pharmova.
    Market Cap of Wockhardt is ₹24,755 Crs.
    While the median market cap of its peers are ₹22,952 Crs.

    Wockhardt seems to be less financially stable compared to its competitors.
    Altman Z score of Wockhardt is 5.83 and is ranked 6 out of its 8 competitors.

    Company Filing
    Discussions & Analysis
    Ideas Dashboard
    Timeline
    Watchlist
    Portfolio
    Alerts
    Research
    Stock Screener
    Market
    Raw Material